Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Pharmaceutical Policy and Practice is Scopus-indexed (Q1, CiteScore 4.4), WoS ESCI, DOAJ. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 2052-3211Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacy | 5 / 52 | 91st | Q1 |
| Health Policy | 98 / 330 | 70th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2013–present, best quartile Q1, CiteScore 4.4.
Journal of Pharmaceutical Policy and Practice is Q1 in Pharmacy (rank 5 of 52) and Q2 in Health Policy (rank 98 of 330), by CiteScore 2025.
Journal of Pharmaceutical Policy and Practice is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.4, which places it in quartile Q1 at the 91st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.740, quartile Q1, with an H-index of 40.
The publisher lists an article processing charge of about US$2,390 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Pharmaceutical Policy and Practice is published by Taylor and Francis Ltd. Its ISSN is 2052-3211.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Journal of Pharmaceutical Policy and Practice has an h-index of 51 and a 2-year mean of 3.3 citations per paper (OpenAlex). Its Scopus CiteScore is 4.4, quartile Q1. On 2-year citations it ranks #4 of 50 Scopus journals in Pharmacy.
Journal of Pharmaceutical Policy and Practice published 149 papers in 2025; its busiest recent year was 2023 with 186. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from Malaysia (10.5%), Thailand (9.7%) and United Kingdom (9.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.